NFKB1 and Parkinson disease: At this regard, recent data indicated that dapagliflozin, a sodium–glucose cotransporter 2 used for treatment of diabetes mellitus and heart failure, may alleviate neuronal oxidative stress by counteracting ROS production and NF-kB pathway activation in animal PD models [101].